Essex Woodlands Health Ventures VIII L.L.C. 13D/13G Filings for Revance Therapeutics, Inc. (RVNC)

Essex Woodlands Health Ventures VIII L.L.C. 13D and 13G filings for Revance Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView